Global Cord Blood Corp Income Statement

Ask AI

Financial Statements

In millions of CNY, except per-share amounts

	FY2022 12 months to Mar 31, 2022	FY2021 12 months to Mar 31, 2021	FY2020 12 months to Mar 31, 2020	FY2019 12 months to Mar 31, 2019	FY2018 12 months to Mar 31, 2018
Direct costs
Revenues
Cost of revenues
Gross profit
Operating expenses
Research and development
Sales and marketing
General and administrative
Total operating expenses
Operating income
Other income, net
Interest income
Interest expense
Foreign currency exchange (losses)/gains
Change in fair value of equity securities
Dividend income
Impairment loss on available-for-sale equity securities
Others
Total other income, net

Income before income tax
Income tax expense
Net income
Net income attributable to non-controlling interests
Net income attributable to Global Cord Blood Corporation's shareholders
Earnings per share:
Basic
Diluted
Other comprehensive losses, net of nil income taxes
Foreign currency translation adjustments
Unrealized holding losses arising during the year
Reclassification adjustment for loss included in net income
Total other comprehensive (losses)/income
Comprehensive income

Comprehensive income attributable to non-controlling interests
Comprehensive income attributable to Global Cord Blood Corporation's shareholders

Comments